infect
influenza
virus
envelop
virus
neg
strand
segment
rna
genom
signific
sourc
global
morbid
mortal
everchang
natur
influenza
virus
allow
agent
continu
evad
host
immun
pose
constant
threat
human
anim
health
acquisit
subtl
alter
antigen
drift
mainli
amino
acid
chang
viral
surfac
protein
hemagglutinin
ha
respons
yearli
occur
influenza
epidem
season
influenza
claim
live
per
year
unit
state
alon
exchang
entir
genom
segment
reassort
influenza
virus
differ
subtyp
coinfect
cell
result
emerg
new
virus
antigen
shift
upon
introduct
immunolog
popul
initi
pandem
spread
pandem
influenza
potenti
sever
medic
social
consequ
estim
million
peopl
world
popul
succumb
influenza
viru
circul
caus
agent
disastr
spanish
influenza
distantli
relat
viru
emerg
mexico
februari
respons
first
influenza
pandem
centuri
laboratori
confirm
case
decemb
number
actual
case
expect
much
higher
albeit
infect
viru
usual
caus
sever
diseas
patient
without
underli
ill
notabl
viru
show
augment
pathogen
anim
model
compar
contemporari
season
influenza
virus
rais
concern
viral
variant
doi
increas
pathogen
might
emerg
cours
pandem
vaccin
antivir
target
viral
surfac
protein
ha
subtyp
neuraminidas
na
subtyp
ion
channel
protein
normal
facilit
entri
ha
releas
na
viral
uncoat
target
cell
howev
variabl
influenza
virus
compromis
antivir
defenc
direct
surfac
protein
thu
result
antigen
drift
vaccin
need
reformul
annual
basi
provid
protect
viral
strain
expect
circul
next
influenza
season
season
vaccin
effect
newli
emerg
virus
like
viru
addit
virus
frequent
acquir
mutat
confer
resist
molecular
target
na
inhibitor
therefor
novel
strategi
combat
influenza
requir
base
thorough
understand
viral
host
cell
factor
essenti
influenza
viru
spread
pathogenesi
proteolyt
activ
influenza
viru
ha
cellular
enzym
indispens
viru
transform
infecti
form
respons
enzym
potenti
target
intervent
howev
natur
proteas
activ
human
influenza
virus
unclear
recent
evid
report
type
ii
transmembran
serin
proteas
ttsp
might
play
major
role
review
knowledg
proteolyt
activ
human
influenza
virus
particular
focu
role
ttsp
discuss
implic
differ
mode
ha
activ
viral
tropism
pathogen
antivir
intervent
ha
mediat
influenza
viru
bind
host
cell
fusion
viral
membran
limit
membran
host
cell
endosom
therebi
provid
viru
access
host
cell
interior
process
essenti
infect
tightli
regul
involv
format
sever
structur
ha
intermedi
characteris
atom
level
describ
ha
bring
membran
fusion
ha
cleavag
essenti
activ
matur
ha
compos
two
subunit
globular
surfac
unit
stalklik
transmembran
unit
coval
link
disulfid
bond
figur
subunit
function
differ
entri
process
facilit
bind
receptor
host
cell
surfac
drive
membran
fusion
import
receptor
determin
influenza
virus
alpha
prefer
human
virus
alpha
prefer
avian
virus
link
sialic
acid
bound
pocket
locat
membran
distal
part
upon
uptak
bound
particl
proceed
via
multipl
endocyt
pathway
low
ph
environ
endosom
vesicl
induc
conform
chang
facilit
membran
fusion
success
membran
merger
requir
concert
action
sever
function
element
includ
ntermin
fusion
peptid
fp
transmembran
domain
central
coil
coil
locat
fp
transmembran
domain
membran
fusion
reaction
commenc
phinduc
looptohelix
transit
sequenc
locat
fp
coil
coil
consequ
transit
hydrophob
fp
propel
toward
target
cell
insert
cellular
membran
subsequ
ctermin
extracellular
portion
fold
onto
central
coil
coil
antiparallel
fashion
form
stabl
postfus
structur
fp
membran
anchor
ha
locat
close
proxim
result
conform
chang
viral
target
cell
membran
pull
close
contact
ultim
fuse
proteolyt
cleavag
essenti
hemagglutinindriven
membran
fusion
cleav
host
cell
proteas
cleavag
occur
linker
sequenc
connect
subunit
locat
partial
surfac
expos
loop
proce
two
step
first
endoproteas
cleav
ha
carboxyl
terminu
arginin
locat
border
therebi
gener
nterminu
matur
subsequ
carboxypeptidas
remov
arginin
therebi
creat
cterminu
matur
cleavag
associ
structur
chang
ha
fp
probabl
due
electrostat
interact
insert
conserv
caviti
form
residu
within
configur
essenti
fusion
sinc
liber
separ
cterminu
fp
abl
insert
target
cell
membran
upon
low
ph
stimulu
amino
acid
within
caviti
fp
essenti
membran
fusion
determin
ph
fusion
trigger
suggest
caviti
fp
potenti
target
therapeut
intervent
natur
linker
sequenc
critic
determin
access
proteas
turn
impact
viral
tropism
pathogen
least
context
avian
virus
thu
low
pathogen
avian
influenza
virus
lpaiv
linker
consist
singl
arginin
case
lysin
access
limit
number
trypsinlik
proteas
tissu
express
proteas
believ
restrict
respiratori
tract
terrestri
bird
gastrointestin
tract
water
fowl
terrestri
bird
consequ
viral
replic
confin
compart
contrast
linker
sequenc
highli
pathogen
avian
influenza
virus
hpaiv
contain
sever
arginin
rxrkr
consensu
motif
sequenc
surfaceexpos
readili
recognis
furin
member
proprotein
convertas
famili
eukaryot
subtilisinlik
serin
endoproteas
ubiquit
express
therefor
hpaiv
replic
system
caus
sever
diseas
context
need
note
hpaiv
harbour
furin
consensu
sequenc
howev
cleavabl
figur
structur
rearrang
associ
influenza
viru
hemagglutinin
cleavag
host
cell
proteas
ha
precursor
cleav
two
subunit
red
blue
cellular
proteas
recognis
either
multibas
monobas
cleavag
site
locat
loop
multibas
cleavag
site
harbour
multipl
arginin
andor
lysin
found
haprotein
hpaiv
monobas
cleavag
site
consist
singl
arginin
arg
purpl
case
influenza
viru
lysin
found
haprotein
human
influenza
virus
lpaiv
upon
proteolyt
cleavag
fusion
peptid
green
liber
ha
prime
activ
low
ph
involv
insert
fusion
peptid
neg
charg
pocket
locat
adjac
cleavag
sitebear
loop
subunit
remain
coval
link
singl
disulfid
bond
yellow
newli
form
cterminu
nterminu
label
purpl
virus
might
increas
due
absenc
carbohydr
side
chain
would
otherwis
limit
recognit
proteas
due
amino
acid
substitut
close
cleavag
site
might
increas
surfac
exposur
sequenc
thu
access
proteas
consid
clear
correl
cleavabl
viral
tropism
pathogen
observ
avian
virus
similar
interdepend
could
also
expect
human
virus
howev
none
influenza
viru
subtyp
previous
pandem
human
contain
multibas
cleavag
site
includ
highli
pathogen
influenza
viru
implic
cleavag
site
spread
pathogen
human
virus
thu
overt
elucid
haactiv
proteas
defin
collect
ha
exhibit
particular
domain
organis
reflect
molecular
mechan
drive
membran
fusion
similar
architectur
membran
fusion
mechan
identifi
viral
glycoprotein
like
hiv
envelop
protein
term
class
fusion
protein
class
fusion
protein
includ
influenza
viru
ha
requir
cleavag
host
cell
proteas
transit
fusioncompet
state
proteolyt
activ
influenza
virus
occur
golgi
apparatu
plasma
membran
infect
cell
well
extracellular
space
target
cell
vesicl
natur
cleavag
site
respect
activ
proteas
import
implic
biolog
properti
influenza
viru
well
therapeut
intervent
discuss
earli
groundbreak
studi
activ
influenza
virus
note
viral
infect
correl
statu
ha
cleavag
activ
virus
trypsin
correl
ha
cleavag
within
studi
also
observ
virus
contain
cleav
ha
highli
infecti
irrespect
cellular
system
use
ha
cleavag
infect
other
strongli
depend
host
cell
virus
former
phenotyp
subsequ
shown
harbour
sever
arginin
lysin
residu
cleavag
site
rxrkr
consensu
sequenc
indispens
effici
cleavag
addit
evid
obtain
cleavag
ha
might
occur
transgolgi
network
tgn
colleagu
demonstr
virus
activ
furin
figur
peptid
deriv
span
rxrkr
consensu
sequenc
abl
suppress
viral
spread
furin
mainli
express
golgi
apparatu
also
found
cell
surfac
process
host
cellular
proprotein
secretori
pathway
indispens
normal
embryon
develop
increas
influenza
viru
pathogen
poultri
associ
acquisit
multibas
cleavag
site
effect
revers
cleavag
site
mutat
underlin
proteas
recognit
site
ha
avian
influenza
virus
import
determin
pathogen
nevertheless
introduct
multibas
cleavag
site
necessarili
suffici
immedi
transform
lpaiv
hpaiv
suggest
determin
ha
cleavag
site
might
contribut
viral
pathogen
besid
influenza
viru
sever
virus
includ
hiv
respiratori
syncyti
viru
chikungunya
viru
misus
furin
potenti
relat
proteas
seven
proprotein
convertas
identifi
human
furin
facilit
activ
cleavag
addit
furin
activ
sever
bacteri
toxin
includ
anthrax
toxin
clostridium
septicum
atoxin
make
furin
relat
enzym
attract
target
therapeut
intervent
identif
proprotein
convertas
highest
activ
pathogen
protein
question
gener
specif
inhibitor
therefor
import
task
activ
human
virus
lpaiv
gener
believ
mediat
solubl
proteas
secret
lung
epitheli
cell
sever
enzym
identifi
includ
among
other
tryptas
clara
miniplasmin
ectop
anion
trypsin
figur
role
proteas
influenza
viru
infect
recent
review
briefli
discuss
solubl
haactiv
proteas
distinct
express
pattern
respiratori
epithelium
identifi
suggest
differ
enzym
might
activ
influenza
virus
differ
section
respiratori
tract
addit
endogen
inhibitor
enzym
like
secretori
leukoproteas
inhibitor
pulmonari
surfact
identifi
shown
inhibit
viral
replic
vitro
experiment
infect
rat
although
observ
suggest
role
solubl
cellular
proteas
influenza
viru
spread
infect
host
direct
evid
support
hypothesi
instanc
reduc
viral
spread
knockout
anim
larg
miss
solubl
bacteri
proteas
gener
staphylococcu
aureu
aerococcu
viridan
strain
also
activ
influenza
virus
sinc
bacteri
superinfect
ie
staphylococcu
aureu
frequent
complic
influenza
conceiv
bacteri
proteas
might
promot
viral
spread
pathogenesi
substanti
fraction
influenza
patient
inde
coinfect
mice
staphylococcu
aureu
strain
secret
haactiv
proteas
influenza
viru
monobas
cleavag
site
caus
sever
diseas
infect
bacteria
viru
alon
induc
overt
symptom
sever
diseas
also
observ
bacteria
inocul
secret
haactiv
proteas
viru
employ
activ
proteas
question
indic
haactiv
staphylococcu
aureu
proteas
pathogen
mechan
underli
describ
observ
summari
solubl
proteas
produc
host
cell
bacteria
activ
influenza
viru
ha
import
contribut
former
enzym
influenza
viru
spread
remain
demonstr
experiment
infect
mice
indic
latter
might
contribut
pneumonia
develop
influenza
patient
bacteri
superinfect
mani
studi
assess
influenza
viru
ha
cleavag
conduct
perman
cell
line
establish
cultur
system
primari
human
lung
epitheli
cell
allow
field
revisit
earlier
find
ha
activ
relev
experiment
model
zhirnov
colleagu
use
primari
human
adenoid
epitheli
cell
haec
studi
proteolyt
activ
influenza
viru
harbour
monobas
cleavag
site
haec
contain
differenti
cell
exhibit
ciliari
motion
secret
mucin
express
marker
clara
cell
thu
consid
adequ
model
epithelium
upper
respiratori
tract
notabl
analysi
system
reveal
ha
cleavag
larg
cell
associ
occur
either
ha
transport
secretori
pathway
product
infect
cell
entri
nonactiv
virus
uninfect
cell
cleavag
reduc
serin
proteas
inhibitor
suggest
enzym
respons
cleavag
influenza
virus
human
respiratori
epithelium
might
cellassoci
serin
proteas
mileston
studi
ttcher
colleagu
provid
evid
elus
proteas
respons
cellassoci
cleavag
influenza
virus
monobas
cleavag
site
might
member
ttsp
famili
human
airway
trypsinlik
proteas
hat
figur
proteas
express
human
lung
engin
express
either
two
enzym
mdck
cell
suffici
support
trypsinindepend
spread
influenza
virus
repres
subtyp
previous
pandem
human
subsequ
studi
wang
et
al
confirm
cleavageactiv
ha
subtyp
hat
chaipan
et
al
show
relat
ttsp
activ
ha
influenza
viru
cleavag
addit
evid
present
mosaic
serin
proteas
larg
form
mspl
splice
variant
thereof
cleav
influenza
viru
haderiv
peptid
particular
multibas
cleavag
site
mrnvpqkkkr
glfg
achickpenn
effici
recognis
furin
although
inform
contribut
ttsp
influenza
viru
spread
miss
present
conceiv
enzym
play
major
role
therefor
introduc
relev
ttsp
detail
member
ttsp
famili
identifi
human
mice
respect
play
import
role
homeostasi
develop
instanc
mutat
associ
deaf
matriptas
requir
surviv
epiderm
barrier
function
hair
follicl
develop
thymic
homeostasi
mice
addit
deregul
ttsp
associ
sever
cancer
ttsp
synthesis
precursor
protein
zymogen
undergo
autoproteolyt
activ
although
disulfid
bond
link
catalyt
domain
membraneinsert
remaind
molecul
releas
proteas
domain
extracellular
space
describ
sever
ttsp
includ
hat
ttsp
exhibit
distinct
domain
organis
ntermin
domain
ttsp
local
cytoplasm
follow
hydrophob
transmembran
domain
stem
region
proteas
domain
contain
catalyt
aa
triad
compos
h
essenti
proteolyt
activ
intracellular
domain
might
interact
compon
cellular
cytoskeleton
well
signal
molecul
might
requir
correct
intracellular
traffick
ttsp
stem
region
might
mediat
proteinprotein
interact
bind
macromolecul
catalyt
domain
cleav
cellmembran
receptor
growth
factor
cytokin
compon
extracellular
matrix
summari
ttsp
famili
compris
sever
enzym
play
import
role
health
diseas
therefor
receiv
increas
attent
recent
year
two
ttsp
cleav
influenza
viru
ha
monobas
cleavag
site
exhibit
ident
domain
organis
figur
lowdens
lipoprotein
receptor
domain
class
ldla
scaveng
receptor
cysteinerich
domain
sr
present
stem
region
enzym
found
third
influenza
viru
haactiv
ttsp
hat
instead
harbour
singl
sea
urchin
sperm
protein
sea
domain
figur
role
domain
ttsp
biolog
ha
recognit
well
understood
proteas
domain
hat
exhibit
high
sequenc
ident
agreement
share
specif
influenza
viru
ha
howev
present
unclear
lack
ha
cleavag
ttsp
instanc
sb
ig
sp
unpublish
observ
due
differ
proteas
domain
spatial
present
proteas
domain
stem
region
localis
cell
surfac
report
mani
ttsp
includ
hat
suggest
ha
cleavag
proteas
occur
upon
insert
ha
plasma
membran
howev
recent
studi
indic
might
differ
localis
ha
cleavag
event
facilit
hat
thu
cleavag
hat
resist
certain
proteas
inhibitor
resist
seem
correl
cleavag
ha
insid
cell
compar
cleavag
plasma
membran
figur
find
implic
inhibitor
develop
sinc
membran
permeabl
inhibitor
requir
block
hat
understand
ha
cleavag
lung
epitheli
cell
furthermor
natur
cellular
compart
ttsp
mediat
ha
cleavag
deserv
characteris
express
known
influenza
virusactiv
ttsp
lung
tissu
detect
express
epithelialcellspecif
fashion
express
found
lung
howev
natur
lung
cell
await
characteris
initi
studi
human
tracheobronchi
epithelium
indic
express
subset
noncili
cell
express
hat
protein
detect
ciliat
cell
bronchial
epithelium
absent
basal
goblet
cell
messeng
rna
detect
varieti
tissu
data
protein
express
larg
miss
messeng
rna
mspl
detect
sever
tissu
includ
lung
mrna
seem
ubiquit
express
remain
determin
hat
coexpress
alpha
alpha
link
sialic
acid
respect
ttspsposit
cell
target
influenza
viru
lung
infect
individu
intrigu
data
influenza
viru
ha
cleavag
ttsp
cell
cultur
stimul
effort
determin
relev
protein
influenza
viru
spread
vivo
express
knockdown
studi
cultur
human
respiratori
epithelium
import
part
endeavour
also
interest
determin
haactiv
ttsp
express
cell
line
support
trypsinindepend
influenza
viru
spread
promin
cell
analysi
knockout
mice
allow
contribut
specif
ttsp
influenza
viru
spread
infect
host
defin
final
clone
function
analysi
respect
ttsp
anim
suscept
influenza
viru
infect
particularli
bird
water
fowl
natur
reservoir
swine
believ
favour
reassort
due
least
part
suscept
infect
virus
differ
receptor
specif
provid
insight
import
enzym
viral
spread
speci
differ
mode
cleavageactiv
discuss
far
involv
proteolyt
cleavag
ha
secretori
pathway
product
infect
cell
cleavag
ha
progeni
particl
releas
extracellular
space
evid
virus
indic
proteolyt
activ
occur
even
attach
progeni
virion
target
cell
envelop
protein
ebola
viru
ebov
sarscoronaviru
activ
endosom
cystein
proteas
cathepsin
b
l
enzym
constitut
potenti
therapeut
target
cathepsin
requir
low
ph
activ
previous
report
phdepend
ebov
sarscoronaviru
entri
due
requir
cathepsin
activ
rather
direct
glycoprotein
activ
low
ph
notabl
activ
target
cell
vesicl
also
describ
influenza
viru
figur
process
observ
mdbk
cell
sensit
serinebut
cystein
proteas
inhibitor
suggest
influenza
viru
activ
target
cell
might
occur
celltyp
depend
fashion
facilit
cathepsin
proteas
respons
influenza
viru
activ
mdbk
cell
remain
identifi
howev
describ
observ
zhirnov
colleagu
ha
activ
occur
upon
influenza
viru
uptak
cultur
respiratori
epithelium
suggest
mode
ha
cleavag
might
import
infect
host
thu
deserv
investig
despit
ampl
possibl
ha
cleavag
discuss
two
promin
influenza
virus
evolv
addit
mechan
depend
presenc
viral
na
one
frequent
studi
neurovirul
laboratori
strain
obtain
extens
passag
parent
viru
differ
anim
spread
infect
mice
limit
brain
lung
tissu
rather
system
suggest
viru
evolv
mechan
ensur
effici
ha
cleavag
broad
spectrum
cell
type
studi
date
back
demonstr
activ
serum
proteas
plasmin
iii
na
specif
adequ
glycosyl
na
requir
neurovirul
mice
work
goto
kawaoka
link
observ
demonstr
na
recruit
serum
plasminogen
upon
convers
plasmin
activ
ha
one
sever
amino
acid
exchang
present
na
parent
na
found
crucial
ha
activ
mutat
number
inactiv
signal
nlink
glycosyl
confer
plasminogen
bind
revers
exchang
abrog
plasminogen
recruit
addit
carboxytermin
lysin
residu
conserv
among
na
subtyp
essenti
plasminogen
recruit
suggest
certain
influenza
viru
na
might
intrins
capac
bind
plasminogen
mask
posttransl
modif
glycan
side
chain
recruit
plasminogen
na
result
expans
viral
tropism
rais
intrigu
question
whether
similar
mechan
might
contribut
spread
influenza
virus
importantli
highli
pathogen
influenza
viru
analysi
na
reveal
presenc
lysin
residu
crucial
plasminogen
bind
also
show
presenc
glycosyl
signal
incompat
plasminogen
recruit
notabl
viru
replic
dog
kidney
cell
line
mdck
high
effici
absenc
trypsin
trypsinindepend
spread
depend
presenc
na
result
suggest
na
also
facilit
ha
cleavag
least
cellular
system
mdck
cell
might
recruit
proteas
subsequ
studi
demonstr
na
na
abl
sequest
plasminogen
activ
ha
convers
unexpectedli
ha
ha
bound
plasminogen
biolog
signific
plasminogen
captur
present
unclear
result
argu
na
facilit
ha
cleavag
manner
directli
compar
na
specul
howev
na
might
recruit
factor
promot
plasminogen
convers
plasmin
like
annexin
ii
shown
incorpor
influenza
viru
particl
support
viral
replic
activ
plasminogen
regardless
present
unclear
mechan
underli
nadepend
ha
cleavag
need
note
process
detect
human
hepatoma
cell
line
human
kidneyderiv
cell
line
thu
uncertain
relev
viru
spread
human
host
final
noteworthi
influenza
viru
season
influenza
viru
replic
human
lung
cell
line
high
effici
absenc
trypsin
cleavag
ha
protein
ttsp
depend
na
might
respons
express
analysi
knockdown
studi
need
test
hypothesi
expect
highli
variabl
rna
viru
usag
na
inhibitor
monotherapi
influenza
trigger
emerg
resist
virus
substanti
proport
current
circul
virus
insensit
least
one
drug
avail
potenti
combin
therapi
therefor
explor
develop
new
drug
imper
cellular
proteas
activ
ha
attract
target
sever
reason
one
essenti
viral
spread
host
cellencod
factor
invari
natur
consequ
latter
properti
viral
resist
due
mutat
drug
target
exclud
alter
cleavag
site
respons
proteas
inhibit
conceiv
howev
import
note
evolut
season
influenza
virus
multibas
cleavag
site
would
confer
resist
inhibitor
direct
proteas
recognis
monobas
cleavag
site
never
observ
human
anoth
advantag
proteas
inhibitor
mere
fact
ampl
proof
concept
alreadi
avail
proteas
inhibitor
document
suppress
influenza
viru
spread
cell
cultur
experiment
infect
anim
importantli
human
major
unwant
side
effect
observ
studi
concern
consid
clinic
develop
proteas
inhibitor
influenza
therapi
howev
identifi
far
describ
haprocess
proteas
inde
support
spread
human
influenza
viru
infect
individu
would
allow
gener
highli
specif
inhibitor
expect
safe
effect
discoveri
ttsp
haactiv
enzym
combin
observ
knockout
phenotyp
mice
might
first
step
direct
cleavag
ha
cellular
proteas
essenti
viru
spread
pathogenesi
respons
proteas
attract
target
intervent
avian
influenza
virus
correl
cleavag
site
sequenc
natur
haprocess
proteas
degre
viral
pathogen
firmli
establish
human
influenza
virus
similar
correl
exist
paradigm
ha
cleavag
shift
cleavag
solubl
proteas
cleavag
cellassoci
proteas
recent
studi
suggest
member
ttsp
famili
specif
hat
mediat
cellassoci
hacleavag
futur
studi
must
defin
import
respect
enzym
proteas
inhibitor
effect
treatment
influenza
ttsp
might
emerg
prime
target
final
inhibitor
ttsp
might
therapeut
valu
condit
other
influenza
sinc
recent
evid
suggest
ttsp
also
involv
proteolyt
activ
human
metapneumoviru
sarscoronaviru
import
role
ttsp
sever
cancer
well
document
